The Merck update, which will shed light on a $588 million bet to succeed Keytruda, is part of a roster of presentations that ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities ...
Add Yahoo as a preferred source to see more of our stories on Google. Roche has announced data from the open-label extension part of its Phase II trial of the BTK inhibitor. Image credit: Shutterstock ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results